Table 3.
Drug resistance patterns of mono-, poly- and multidrug-resistant TB isolates in Lambaréné (2012–2013)
| RIF | INH | PZA | EMB | STR | OFX | ETO | CS | AM | PAS | CM | Species | Clinical information (history of TB; outcome9) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mono-resistance to first-line drugs (N = 7) | |||||||||||||
| n = 2 | S | R | S | S | S | S | S | S | S | S | S | Mtb | New TB; not evaluated (1), completed (1) |
| n = 1 | S | R | S | S | S | S | R | S | S | S | S | Mtb | New TB; lost to follow-up |
| n = 1 | S | R | S | S | S | R | S | S | S | S | S | Maf | New TB; completed |
| n = 3 | S | S | S | S | R | ND | ND | ND | ND | ND | ND | Mtb | New TB (1), retreatment (2); completed (2), cured (1) |
| Poly-resistance to first-line drugs (N = 2) | |||||||||||||
| n = 1 | S | R | S | S | R | S | S | S | S | S | S | Mtb | New TB; completed |
| n = 1 | S | R | S | S | R | S | R | S | S | S | S | Maf | New TB; cured |
| Multidrug resistance (N = 8) | |||||||||||||
| n = 1 | R | R | S | R | R | S | R | S | S | S | S | Mtb | New TB; died |
| n = 1 | R | R | S | R | R | R | S | S | S | R | S | Mtb | New TB; not evaluated |
| n = 1 | R | R | R | R | R | S | S | S | S | S | S | Mtb | Retreatment; died |
| n = 1 | R | R | R | R | R | S | S | S | S | S | S | Mtb | New TB; died |
| n = 1 | R | R | R | R | R | S | R | S | S | S | S | Mtb | Retreatment; completed (first-line treatment) |
| n = 1 | R | R | S | R | R | S | B | S | S | S | S | Mtb | Retreatment; not evaluated |
| n = 1 | R | R | S | S | S | S | R | S | S | S | S | Mtb | Retreatment; died |
| n = 1 | R | R | R | R | R | S | R | S | S | S | S | Mtb | New TB; failure (first-line treatment) |
AM = amikacin; B = borderline; CM = capreomycin; CS = cycloserine; EMB = ethambutol; ETO = ethionamide; INH = isoniazid; Mtb = Mycobacterium tuberculosis; Maf = Mycobacterium africanum; ND = not done; OFX = ofloxacin; PAS = 4-aminosalicylic acid; PZA = pyrazinamide; R = resistant; RIF = rifampicin; S = sensitive; STR = streptomycin; TB = tuberculosis. Sample collection period: June 2012 to October 2013.